secwatch.observer — SEC 8-K summary
======================================

Issuer:     AEMETIS, INC (AMTX)
CIK:        0000738214
Form:       8-K
Filed at:   2024-03-07T23:59:59+00:00
Accession:  0001437749-24-006893
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aemetis reports 2023 revenue $186.7M, net loss $46.4M; India biodiesel sales up 175%
--------------------------------------------------------------------------------

- Q4 revenue $70.8M (up from $66.7M YoY); net loss $25.4M vs $22.4M prior year.
- Full-year revenue $186.7M (down from $257M); India biodiesel segment revenue $77.2M (+175%).
- Adjusted EBITDA plus IRA tax credit sales generated $32.7M positive cash flow in 2023.
- Aemetis repaid $50.2M of Third Eye Capital debt; extended $108M at 8.5% interest.
- Received D3 RIN approval for RNG; commissioned 36-mile biogas pipeline; increased biogas capacity 300%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/738214/000143774924006893/0001437749-24-006893-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/738214/000143774924006893/amtx20240306_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-006893

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer